Outcome of Board Meeting

November 04, 2026 Ref: NIVABUPA/EQ/2026-27/52 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai – 400 051 Mumbai – 400 001 Symbol: NIVABUPA Scrip Code: 544286 Sub: Outcome of the Board Meeting held on November 04, 2026 Ref: Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, We hereby inform you that the Board of Directors (‘the Board’) of the Company, at their meeting held today i.e. on Wednesday, November 04, 2026, inter-alia, has considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026, based on recommendation of the Audit Committee. A copy of the said results along with limited review report issued by Joint Statutory Auditors thereon, is enclosed herewith as Annexure-I. The meeting of the Board commenced at 02:30 P.M. (IST) and concluded at 03:10 P.M. (IST). Kindly take the same on records. Thanking you, Yours Sincerely, For Niva Bupa Health Insurance Company Limited Aparna Sharma Company Secretary and Compliance Officer Niva Bupa Health Insurance Company Limited IRDAI Registration No. 145 | CIN: L66000DL2008PLC182918 Registered Office: C-98, First Floor, Lajpat Nagar, Part 1, Delhi-110024 Corporate Office: 3rd Floor, Capital Cyber scape, Golf Course Extension Road, Sector-59, Gurugram-122101, Haryana. Website: www.nivabupa.com | Email id: investor@nivabupa.com I Tel: +91-124-6354900 S.R. Batliboi & Co. LLP Nangia & Co LLP Chartered Accountants Chartered Accountants 12thFloor, The Ruby, A-109, Sector 136, 29 Senapati Bapat Marg, Noida -201304 Dadar (West), Mumbai-400 028 India Telephone +91 22 6819 8000 Telephone +91 1202598000 and year to date unaudited Financial Results of the Company Pursuant to the Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to The Board of Directors Niva Bupa Health Insurance Company Limited 1. We have reviewed the accompanying statement of unaudited financial results of Niva Bupa Health Insurance Company Limited for the quarter and six months period endedSeptember 30, 2026 , being submitted by the Company pursuant to the requirement of Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including relevant circulars issued by the SEBI from time to IRDAI ) circular reference IRDAI/F&I/CIR/MISC/92/7/2026 dated July 8, 2026. This Statement is the responsibility of the Company's Management and has been approved by the Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review. 2. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement isfree of material misstatement. A review is limited primarily to inquiries of Company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 3. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement prepared in accordance with the requirements of, the recognitionand measurement principles laid down in Indian Accounting Standard Ind AS 34 prescribed under section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India, to the extent applicable and the accounting and presentation principles as prescribed in the relevant provisions of the Insurance Act, 1938 as amended by the Insurance Laws (Amendment) Act, 2015 (the "Insurance Act"), the Insurance Regulatory and Development Authority Act, 1999 (the "IRDA Act") and the Insurance Regulatory and Development Authorityof India(Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024 read with Master Circular No. IRDAI/ACTL/CIR/MISC/80/05/2024 dated May 17, 2024, the Insurance Regulatory and Development Authority (Actuarial, Finance and Investment Functions of Ito the extent applicable in the manner so required,as amended from time to time, has not disclosed the information required to be disclosed in terms of Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and IRDAI circular reference IRDAI/F&I/CIR/MISC/92/7/2026 dated July 8, 2026, to the extent applicable, including the manner in which it is to be disclosed, or that it contains any material misstatement. For S.R. Batliboi & Co. LLP ForNangia & Co LLP Chartered Accountants Chartered Accountants FRN No.301003E/E300005 FRN No. 002391C/N500069 Shrawan Digitally signed by Shrawan Bhagwati Jalan Bhagwati DN: cn=Shrawan Bhagwati Jalan, c=IN, o=Personal Jalan D +0a 5te '3: 02 '026.11.04 15:01:37 per Shrawan Jalan Vikas Gupta Partner Partner Membership No. 102102 Membership No. 076879 UDIN:26102102IVXUEW1718 UDIN:26076879ZTQIIS7735 Place: Mumbai Place: Noida Date: November 4, 2026 Date: November 4, 2026 Annexure-I NIVA BUPA HEALTH INSURANCE COMPANY LIMITED CIN: L66000DL2008PLC182918 REGISTRATION NO: 145, DATE OF REGISTRATION WITH IRDAI: FEBRUARY 15, 2010 Registered Address- C-98, First Floor Lajpat Nagar, Part 1 New Delhi - 110024, India Pursuant to the Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements ) Regulations, 2015 read with IRDAI Circular reference : IRDAI/F&I/CIR/MISC/92/7/2026 dated 8th July, 2026 Statement of Unaudited Financial Results for the Quarter and Year to date ended September 30, 2026 (Rs. in lakhs) Corresponding 3 Year to date for Year to date for Preceding 3 Previous year 3 months ended months ended in current period the previous year months ended ended Sl. No. Particulars the previous year ended ended (30/09/2026) (30/06/2026) (30/09/2025) (30/09/2026) (30/09/2025) (31/03/2026) Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited 1 Insurance Revenue (i) Contracts not measured under the PAA - - - - - - (ii) Contracts measured under the PAA 2,41,227 2,27,372 1,89,907 4,68,599 3,66,768 7,82,910 Total Insurance Revenue 2,41,227 2,27,372 1,89,907 4,68,599 3,66,768 7,82,910 2 Insurance Service Expenses (i) Incurred Claims (1,53,335) (1,44,381) (1,24,473) (2,97,716) (2,43,533) (5,07,421) (ii) Losses and reversals on onerous contracts - - - - - (4,501) (iii) Adjustments to liabilities for incurred claims - - - - - - (iv) Employee benefit expenses (21,756) (19,880) (17,669) (41,636) (35,008) (71,171) (v) Commission (56,578) (46,408) (47,167) (1,02,986) (89,539) (1,97,953) (vi) Other expenses (17,608) (19,513) (14,006) (37,121) (22,169) (51,721) Adjustment for insurance acquisition cash flow amortisation (70,448) (66,612) (57,803) (1,37,060) (1,11,557) (2,36,008) Other Adjustments (i) Amounts attributed to insurance acquisition cash flows 84,113 72,369 66,339 1,56,482 1,25,570 2,82,588 (ii) Release of loss component on onerous contracts 1,135 1,122 876 2,257 1,743 3,765 (iii) Costs not directly attributed to insurance contracts 9,660 10,595 10,424 20,255 16,811 32,900 Total Insurance Service Expenses (2,24,817) (2,12,708) (1,83,479) (4,37,525) (3,57,682) (7,49,522) 3 Net expenses/income from reinsurance contracts (i) Contracts not measured under the PAA - - - - - - (ii) Contracts measured under the PAA (3,811) (4,575) (1,874) (8,386) (3,773) (11,982) Total Net expenses/income from reinsurance contracts (3,811) (4,575) (1,874) (8,386) (3,773) (11,982) 4 Insurance Service Result (Total of 1 to 3) 12,599 10,089 4,554 22,688 5,313 21,406 5 Inve [Showing first 8,000 characters — download PDF for full document]